Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs

Journal of Veterinary Internal Medicine

Volumn 23, Issue 5, 2009, Pages 1003-1006

  Sayer, M B ^a   Atkins, C E ^c   Fujii, Y ^b   Adams, A K ^c   DeFrancesco, T C ^c   Keene, B W ^c  

^a Carolina Veterinary Specialists Medical Center   (United States)

^b AZABU UNIVERSITY   (Japan)

^c NONE

Author keywords

Furosemide; Heart failure; Inodilator; Pimobendan; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; CHLORIDE; FUROSEMIDE; LOOP DIURETIC AGENT; PHOSPHORUS; PIMOBENDAN; POTASSIUM; PYRIDAZINE DERIVATIVE; SODIUM; VASODILATOR AGENT;

ANIMAL; ARTICLE; BLOOD; CROSSOVER PROCEDURE; DOG; DRUG EFFECT; FEMALE; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UREA NITROGEN BLOOD LEVEL; URINE;

ALDOSTERONE; ANIMALS; BLOOD UREA NITROGEN; CHLORIDES; CROSS-OVER STUDIES; DOGS; FEMALE; FUROSEMIDE; MALE; PHOSPHORUS; POTASSIUM; PYRIDAZINES; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; VASODILATOR AGENTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 70349653180     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0367.x     Document Type: Article

References (14)

1. Lovern CS, Swecker WS, Lee JC, Moon ML. Additive effects of sodium and chloride restricted diets and furosemide administration in healthy dogs. Am J Vet Res 2001;62:1783-1796.
2. Kammerl MC, Rolf MN, Schweda F, et al. Low sodium and furosemide-induced stimulation of the renin system in man mediated by cyclooxygenase2. Clin Pharm Ther 2001;70:468-473.
3. Atkins CE, Rausch WP, Gardner SY, et al. Effects of amlodipine and the combination of amlodipine and enalapril on the reninangiotensin aldosterone system in the dog. J Vet Pharmacol Ther 2007;30:394-400.
4. Haggstrom J, Hansson K, Karlberg BE, et al. Effects of long term treatment with enalapril or hydralazine on the renin-angiotensin aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am J Vet Res 1996;57:1645-1651.
5. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585.
6. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-1697.
7. Luis-Fuentes V. Use of pimobendan in the management of heart failure. Vet Clin North Am Small Anim Pract 2004;34:1145-1155.
8. Gordon S, Miller M, Saunders A. Pimobendan in heart failure therapy-A silver bullet? J Am Anim Hosp Assoc 2006;42:90-93.
9. Luis-Fuentes V, Cocoran B, French A, et al. A double-blind randomized placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Int Med 2002;16:255-261.
10. Smith P, French AT, Van Israel N, et al. Long-term efficacy of pimobendan in slight-to-moderate heart failure caused by myxomatous mitral valve disease in dogs. A prospective, single-blind, parallel, 6-month comparison with ramipril. J Small Anim Pract 2005;46:121-130.
11. Haggstrom J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study. J Vet Intern Med 2008;22:1124-1135.
12. Lombard CW, Jons O, Bussadori CM. Veterinary study for the confirmation of pimobendan in canine endocardiosis. J Am Anim Hosp Assoc 2006;42:249-261.
13. Gardner SY, Atkins CE, Rausch WP, et al. Estimation of 24-h aldosterone secretion in the dog, using urine aldosterone: Creatinine. J Vet Cardiol 2007;9:1-7.
14. Tidholm A, Haggstrom J, Hansson, et al. Effects of dilated cardiomyopathy on the rennin-angiotensin-aldosterone system, atrial natriuretic peptide, and thyroid hormone concentrations in dogs. Am J Vet Res 2001;62:961-967.